Osphena | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Osphena
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Osphena

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 8 USDMF, 1 EU WC, 4 NDC API, 5 Listed Suppliers, $ API Reference Price

13 API Suppliers
8 USDMF
1 EU WC
4 NDC API
5 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 2 FDA Orange Book, 1 Europe, 1 Canada, 1 Listed Dossiers

5 FDF Dossiers
2 FDA Orange Book
1 Europe
1 Canada
1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 17 SPI Pharma, 5 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 3 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 19 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 1 Finar, 7 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 29 Direct Compression, 24 Granulation, 22 Disintegrants & Superdisintegrants, 21 Controlled & Modified Release, 20 Thickeners and Stabilizers, 18 Chewable & Orodispersible Aids, 16 Taste Masking, 12 Co-Processed Excipients, 12 Solubilizers, 11 Lubricants & Glidants, 8 Topical, 8 Film Formers & Plasticizers, 7 Parenteral, 5 Empty Capsules, 4 Emulsifying Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Coloring Agents

62 Fillers, Diluents & Binders
40 Coating Systems & Additives
29 Direct Compression
24 Granulation
22 Disintegrants & Superdisintegrants
21 Controlled & Modified Release
20 Thickeners and Stabilizers
18 Chewable & Orodispersible Aids
16 Taste Masking
12 Co-Processed Excipients
12 Solubilizers
11 Lubricants & Glidants
8 Topical
8 Film Formers & Plasticizers
7 Parenteral
5 Empty Capsules
4 Emulsifying Agents
4 Rheology Modifiers
4 Vegetarian Capsules
4 API Stability Enhancers
4 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 8 News #PharmaBuzz

1 Data Compilation #PharmaFlow
8 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

2 US Medicaid Prescriptions

MARKET PLACE

9 APIs

9 APIs

PATENTS & EXCLUSIVITIES

6 US Patents, 3 Health Canada Patents

6 US Patents
3 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,701 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Duchesnay Inc.

filter Patent Reset all filters

3 All

01 12484542

02 12554695

03 12556089

filter Product Reset all filters

3 All

01 3OSPEMIFENE

filter Dosage Reset all filters

3 All

01 3TABLET

filter Exp Date Reset all filters

3 All

01 12023-05-14

02 12025-01-14

03 12025-01-19

Product Main Page

01

Duchesnay Inc.

Ospemifene

Peptide Process CMC

Not Confirmed

Duchesnay Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-14

Date Granted : 2010-11-02

Brand Name : OSPHENA

Patent Number : 2484542

Filing Date : 2003-05-14

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-05-14

Date Granted : 2010-11-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Duchesnay Inc.

Ospemifene

Peptide Process CMC

Not Confirmed

Duchesnay Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-01-19

Date Granted : 2013-03-05

Brand Name : OSPHENA

Patent Number : 2554695

Filing Date : 2005-01-19

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-01-19

Date Granted : 2013-03-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Duchesnay Inc.

Ospemifene

Peptide Process CMC

Not Confirmed

Duchesnay Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-01-14

Date Granted : 2013-04-02

Brand Name : OSPHENA

Patent Number : 2556089

Filing Date : 2005-01-14

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-01-14

Date Granted : 2013-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!